Related references
Note: Only part of the references are listed.Effects of Macitentan and Its Active Metabolite on Cultured Human Systemic Sclerosis and Control Skin Fibroblasts
Maurizio Cutolo et al.
JOURNAL OF RHEUMATOLOGY (2015)
Comparison of pharmacological activity of macitentan and bosentan in preclinical models of systemic and pulmonary hypertension
Marc Iglarz et al.
LIFE SCIENCES (2014)
Impaired Endothelium-Mesenchymal Stem Cells Cross-talk in Systemic Sclerosis: a Link Between Vascular and Fibrotic Features
Paola Cipriani et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Bosentan reverses the pro-fibrotic phenotype of systemic sclerosis dermal fibroblasts via increasing DNA binding ability of transcription factor Fli1
Kaname Akamata et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Impaired Cav-1 expression in SSc mesenchymal cells upregulates VEGF signaling: a link between vascular involvement and fibrosis
Paola Cipriani et al.
FIBROGENESIS & TISSUE REPAIR (2014)
Scleroderma Mesenchymal Stem Cells display a different phenotype from healthy controls; implications for regenerative medicine
Paola Cipriani et al.
ANGIOGENESIS (2013)
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative
Frank van den Hoogen et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
2013 Classification Criteria for Systemic Sclerosis An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative
Frank van den Hoogen et al.
ARTHRITIS AND RHEUMATISM (2013)
Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities
Swati Bhattacharyya et al.
NATURE REVIEWS RHEUMATOLOGY (2012)
BUILD-3: A Randomized, Controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis
Talmadge E. King et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
The Paradigm of G Protein Receptor Transactivation: A Mechanistic Definition and Novel Example
Peter J. Little et al.
THESCIENTIFICWORLDJOURNAL (2011)
Endothelin receptors: what's new and what do we need to know?
Stephanie W. Watts
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2010)
Endothelial-Mesenchymal Transition in Bleomycin-Induced Pulmonary Fibrosis
Naozumi Hashimoto et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2010)
Endothelin 1 Contributes to the Effect of Transforming Growth Factor beta 1 on Wound Repair and Skin Fibrosis
David Lagares et al.
ARTHRITIS AND RHEUMATISM (2010)
Endothelin Receptor Antagonists for Pulmonary Arterial Hypertension: An Overview
Shahzad G. Raja
CARDIOVASCULAR THERAPEUTICS (2010)
Thrombin Stimulation of Proteoglycan Synthesis in Vascular Smooth Muscle Is Mediated by Protease-activated Receptor-1 Transactivation of the Transforming Growth Factor β Type I Receptor
Micah L. Burch et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Pathogenesis and therapeutic approaches for improved topical treatment in localized scleroderma and systemic sclerosis
I. Badea et al.
RHEUMATOLOGY (2009)
BUILD-1: A randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis
Talmadge E. King et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Endothelin: 20 years from discovery to therapy
Matthias Barton et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2008)
Targeting the TGFβ, endothelin-1 and CCN2 axis to combat fibrosis in scleroderma
Andrew Leask
CELLULAR SIGNALLING (2008)
Transforming Growth Factor β-Induced Smad1/5 Phosphorylation in Epithelial Cells Is Mediated by Novel Receptor Complexes and Is Essential for Anchorage-Independent Growth
Amanda C. Daly et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Endothelin is a downstream mediator of profibrotic responses to transforming growth factor β in human lung fibroblasts
Xu Shi-wen et al.
ARTHRITIS AND RHEUMATISM (2007)
Endogenous endothelin-1 signaling contributes to type I collagen and CCN2 overexpression in fibrotic fibroblasts
Shi-Wen Xu et al.
MATRIX BIOLOGY (2007)
Detection of epithelial to mesenchymal transition in airways of a bleomycin induced pulmonary fibrosis model derived from an α-smooth muscle actin-Cre transgenic mouse
Zhuang Wu et al.
RESPIRATORY RESEARCH (2007)
Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix
Kevin K. Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Constitutive ALKS-independent C-jun N-terminal kinase activation contributes to endothelin-1 overexpression in pulmonary fibrosis: Evidence of an autocrine endothelin loop operating through the endothelin A and B receptors
Xu Shi-Wen et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Contribution of activin receptor-like kinase 5 (Transforming growth factor β receptor type I) signaling to the fibrotic phenotype of scleroderma fibroblasts
YL Chen et al.
ARTHRITIS AND RHEUMATISM (2006)
Signalling and regulation of collagen I synthesis by ET-1 and TGF-β1
A Horstmeyer et al.
FEBS JOURNAL (2005)
TGF-β signaling and the fibrotic response
A Leask et al.
FASEB JOURNAL (2004)
Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac/phosphoinositide 3-kinase/akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts
SW Xu et al.
MOLECULAR BIOLOGY OF THE CELL (2004)
Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFP/ALK5 signaling
MJ Goumans et al.
MOLECULAR CELL (2003)
Balancing the activation state of the endothelium via two distinct TGF-β type I receptors
MJ Goumans et al.
EMBO JOURNAL (2002)
Transforming growth factor-β and connective tissue growth factor:: key cytokines in scleroderma pathogenesis
CP Denton et al.
CURRENT OPINION IN RHEUMATOLOGY (2001)
Tethering of the platelet-derived growth factor ß receptor to G-protein-coupled receptors -: A novel platform for integrative signaling by these receptor classes in mammalian cells
F Alderton et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Insulin activation of mitogen-activated protein kinases Erk1,2 is amplified via β-adrenergic receptor expression and requires the integrity of the Tyr350 of the receptor
HY Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
A cytokine reborn? Endothelin-1 in pulmonary inflammation and fibrosis
P Teder et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2000)
Share Paper
